Loading…

AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts — freecase.ai

Search Pricing About Why now Resources Guides

Opinion

AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts

177 L. Ed. 2d 1150 · Supreme Court of the United States · Sep 28, 2010

Full text

AstraZeneca Pharmaceuticals LP v. Blue Cross Blue Shield of Massachusetts

The petition for writ of certiorari to the United States Court of Appeals for the First Circuit in the above-entitled case was dismissed today pursuant to Rule 46 of the Rules of this Court. Same case below, 582 F.3d 156.

Notice

Freecase is a legal research tool. It does not determine whether a case is good law and does not provide legal advice.

Metadata

Status: Published
Author
Judges: Not listed
Cluster ID: 7337324

Citations

177 L. Ed. 2d 1150
131 S. Ct. 60
561 U.S. 1056
2010 U.S. LEXIS 5762

Cited by

Federated Ins. Co. v. Summit Pharmacy (WC Fee Rev. Hearing Office)
Commonwealth Court of Pennsylvania · Jan 2, 2024
Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Commonwealth Court of Pennsylvania · Jul 26, 2012
Commonwealth v. Tap Pharmaceutical Products, Inc.
Commonwealth Court of Pennsylvania · Aug 31, 2011

Parentheticals

extensive expert damage testimony quantifying overpayments caused by deceptive drug pricing
Commonwealth v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.

© 2026 freecase.aicontact@freecase.aiBuilt by lawyers. Powered by AI.

Freecase.ai provides legal information for educational and research purposes only. It is not legal advice and does not create an attorney-client relationship. Always consult a licensed attorney for legal guidance. Terms of Service